OpenURL Connection Search

Select item for more details and to access through your institution.

Characterization of cerebral radiation necrosis following the treatment of sinonasal malignancies.
Published in:
Laryngoscope Investigative Otolaryngology, 2024, v. 9, n. 2, p. 1, doi. 10.1002/lio2.1200
By:
- Wu, Eric L.;
- Patel, Atur;
- McGunigal, Mary C.;
- Johng, Stephanie Y.;
- Mortazavi, Armin;
- Jay, Ann K.;
- Ahn, Peter H.;
- Anaizi, Amjad N.;
- DeKlotz, Timothy R.
Publication type:
Article
A novel PARD3B-NUTM1 fusion in an aggressive primary CNS embryonal tumor in a young adult.
Published in:
2020
By:
- Ko, Kyungmin;
- Kitani, Takashi;
- Harris, Brent T.;
- Anaizi, Amjad N.;
- Solomon, David;
- Perry, Arie;
- Toretsky, Jeffrey;
- Ozdemirli, Metin
Publication type:
Letter
Prospective evaluation of 1-year outcomes in single-level percutaneous lumbar transfacet screw fixation in the lateral decubitus position following lateral transpsoas interbody fusion.
Published in:
2015
By:
- Rhee, Jay;
- Petteys, Rory;
- Anaizi, Amjad;
- Sandhu, Faheem;
- Voyadzis, Jean-Marc;
- Rhee, Jay W;
- Petteys, Rory J;
- Anaizi, Amjad N;
- Sandhu, Faheem A
Publication type:
journal article
Volume of Disease as a Predictor for Clinical Outcomes in Patients With Melanoma Brain Metastases Treated With Stereotactic Radiosurgery and Immune Checkpoint Therapy.
Published in:
Frontiers in Oncology, 2022, v. 11, p. 1, doi. 10.3389/fonc.2021.794615
By:
- Burke, Aidan M.;
- Carrasquilla, Michael;
- Jean, Walter C.;
- Collins, Brian T.;
- Anaizi, Amjad N.;
- Atkins, Michael B.;
- Gibney, Geoffrey T.;
- Collins, Sean P.
Publication type:
Article

Found: 4

Characterization of cerebral radiation necrosis following the treatment of sinonasal malignancies.

A novel PARD3B-NUTM1 fusion in an aggressive primary CNS embryonal tumor in a young adult.

Prospective evaluation of 1-year outcomes in single-level percutaneous lumbar transfacet screw fixation in the lateral decubitus position following lateral transpsoas interbody fusion.

Volume of Disease as a Predictor for Clinical Outcomes in Patients With Melanoma Brain Metastases Treated With Stereotactic Radiosurgery and Immune Checkpoint Therapy.